Apigenin impairs oral squamous cell carcinoma growth in vitro inducing cell cycle arrest and apoptosis

International Journal of Oncology

Volumn 43, Issue 5, 2013, Pages 1675-1682

  Maggioni, Daniele ^a   Garavello, Werner ^a,b   Rigolio, Roberta ^a   Pignataro, Lorenzo ^c   Gaini, Renato ^a,b   Nicolini, Gabriella ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Apigenin; Cell cycle; HaCaT and SCC 25; Oral squamous cell carcinoma

Indexed keywords

APIGENIN; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE 1; CYCLIN E; CYCLINE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PROPIDIUM IODIDE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CELL ASSAY; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; M PHASE CELL CYCLE CHECKPOINT; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TONGUE CARCINOMA; WESTERN BLOTTING;

APIGENIN; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL CYCLE PROTEINS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; KERATINOCYTES; TONGUE NEOPLASMS;

EID: 84885073826     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2072     Document Type: Article

References (30)

1. Jemal A, Siegel R, Xu J and Ward E: Cancer statistics. CA Cancer J Clin 60: 277-300, 2010.
2. Garavello W, Bertuccio P, Levi F, Lucchini F, Bosetti C, Malvezzi M, Negri E, La Vecchia C: The oral cancer epidemic in central and eastern Europe. Int J Cancer 127: 160-171, 2010.
3. Shiboski CH, Schmidt BL and Jordan RC: Tongue and tonsilar carcinoma: increasing trends in the US population ages 20-44 years. Cancer 103: 1843-1849, 2005.
4. Bonifazi M, Malvezzi M, Bertuccio P, Edefonti V, Garavello W, Levi F, La Vecchia C, Negri E: Age-period-cohort analysis of oral cancer mortality in Europe: the end of an epidemic? Oral Oncol 47: 400-407, 2011.
5. Warnakulasuriya S: Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival. Oral Oncol 46: 407-410, 2010.
6. Rossi M, Garavello W, Talamini R, Negri E, Bosetti C, Dal Maso L, Lagiou P, Tavani A, Polesel J, Barzan L, Ramazzotti V, Franceschi S, La Vecchia C: Flavonoids and the risk of oral and pharyngeal cancer: a case-control study from Italy. Cancer Epidemiol Biomarkers Prev 16: 1621-1625, 2007.
7. Shukla S and Gupta S: Apigenin: a promising molecule for cancer prevention. Pharm Res 27: 962-978, 2010.
8. Patel D, Shukla S and Gupta S: Apigenin and cancer chemoprevention: progress, potential and promise (Review). Int J Oncol 30: 233-245, 2007.
9. Gupta S, Afaq F and Mukhtar H: Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun 287: 914-920, 2001.
10. Choi EJ and Kim GH: Apigenin induces apoptosis through a mtochondria/caspase-pathway in human breast cancer MDA-MB-453 cells. J Clin Biochem Nutr 44: 260-265, 2009.
11. Zhong Y, Krisanapun C, Lee SH, Nualsanit T, Sams C, Peungvicha P and Baek SJ: Molecular targets of apigenin in colorectal cancer cells: involvement of p21, NAG-1 and p53. Eur J Cancer 46: 3365-3374, 2010.
12. Xu Y, Xin Y, Diao Y, Lu C, Fu J, Luo L and Yin Z: Synergistic effects of apigenin and paclitaxel on apoptosis of cancer cells. PLoS One 6: e29169, 2011.
13. Kaur P, Shukla S and Gupta S: Plant flavonoid apigenin inactivates Akt to trigger apoptosis in human prostate cancer: an in vitro and in vivo study. Carcinogenesis 29: 2210-2217, 2008.
14. Pandey M, Kaur P, Shukla S, Abbas A, Fu P and Gupta S: Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog 51: 952-962, 2012.
15. Wei H, Tye L, Bresnick E and Birt DF: Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res 50: 499-502, 1990.
16. O'Prey J, Brown J, Fleming J and Harrison PR: Effects of dietary flavonoids on major signal transduction pathways in human epithelial cells. Biochem Pharmacol 66: 2075-2088, 2003.
17. Masuelli L, Marzocchella L, Quaranta A, Palumbo C, Pompa G, Izzi V, Canini A, Modesti A, Galvano F and Bei R: Apigenin induces apoptosis and impairs head and neck carcinomas EGFR/ErbB2 signaling. Front Biosci 16: 1060-1068, 2011.
18. Scott RE, Wilke MS, Wille JJ Jr, Pittelkow MR, Hsu BM and Kasperbauer JL: Human squamous carcinoma cells express complex defects in the control of proliferation and differentiation. Am J Pathol 133: 374-380, 1988.
19. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A and Fusenig NE: Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106: 761-771, 1988.
20. Komissarova EV and Rossman TG: Arsenite induced poly(ADP-ribosyl)ation of tumor suppressor P53 in human skin keratinocytes as a possible mechanism for carcinogenesis associated with arsenic exposure. Toxicol Appl Pharmacol 243: 399-404, 2010.
21. Lu HF, Chie YJ, Yang MS, Lee CS, Fu JJ, Yang JS, Tan TW, Wu SH, Ma YS, Ip SW and Chung JG: Apigenin induces caspase-dependent apoptosis in human lung cancer A549 cells through Bax- and Bcl-2-triggered mitochondrial pathway. Int J Oncol 36: 1477-1484, 2010.
22. Abu-Yousif AO, Smith KA, Getsios S, Green KJ, Van Dross RT and Pelling JC: Enhancement of UVB-induced apoptosis by apigenin in human keratinocytes and organotypic keratinocyte cultures. Cancer Res 68: 3057-3065, 2008.
23. Ujiki MB, Ding XZ, Salabat MR, Bentrem DJ, Golkar L, Milam B, Talamonti MS, Bell RH Jr, Iwamura T and Adrian TE: Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol Cancer 5: 76, 2006.
24. Lepley DM, Li B, Birt DF and Pelling JC: The chemopreventive flavonoid apigenin induces G2/M arrest in keratinocytes. Carcinogenesis 17: 2367-2375, 1996.
25. McVean M, Weinberg WC and Pelling JC: A p21(waf1)-independent pathway for inhibitory phosphorylation of cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by the chemopreventive flavonoid apigenin. Mol Carcinog 33: 36-43, 2002.
26. Parker LL and Piwnica-Worms H: Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science 257: 1955-1957, 1992.
27. Casagrande F and Darbon JM: Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol 61: 1205-1215, 2001.
28. Lepley DM and Pelling JC: Induction of p21/WAF1 and G1 cell-cycle arrest by the chemopreventive agent apigenin. Mol Carcinog 19: 74-82, 1997.
29. Shintani S, Mihara M, Nakahara Y, Kiyota A, Ueyama Y, Matsumura T and Wong DT: Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol 38: 235-243, 2002.
30. Yamada S, Sumrejkanchanakij P, Amagasa T and Ikeda MA: Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway. Int J Cancer 111: 17-22, 2004.